Prevest Denpro (PREVEST) | Financial Analysis & Statements
Prevest Denpro Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
157.7M
Gross Profit
122.1M
77.43%
Operating Income
48.2M
30.58%
Net Income
44.1M
27.94%
EPS (Diluted)
₹3.67
Balance Sheet Metrics
Total Assets
1.1B
Total Liabilities
69.6M
Shareholders Equity
1.1B
Debt to Equity
0.07
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Prevest Denpro Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 620.8M | 559.1M | 498.5M | 381.1M | 274.4M |
| Cost of Goods Sold | 122.5M | 135.6M | 126.1M | 97.8M | 78.9M |
| Gross Profit | 498.3M | 423.5M | 372.5M | 283.3M | 195.5M |
| Gross Margin % | 80.3% | 75.8% | 74.7% | 74.3% | 71.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | 1.6M |
| Selling, General & Administrative | 100.5M | 72.0M | 52.1M | 34.8M | 39.8M |
| Other Operating Expenses | 69.1M | 56.7M | 39.8M | 30.6M | 27.5M |
| Total Operating Expenses | 169.5M | 128.8M | 91.9M | 65.4M | 68.8M |
| Operating Income | 205.1M | 187.8M | 191.3M | 147.0M | 85.7M |
| Operating Margin % | 33.0% | 33.6% | 38.4% | 38.6% | 31.2% |
| Non-Operating Items | |||||
| Interest Income | 36.8M | 25.4M | 16.2M | 13.2M | 5.1M |
| Interest Expense | 0 | 0 | 0 | 1.0M | 1.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 242.5M | 214.3M | 209.6M | 160.5M | 93.4M |
| Income Tax | 60.9M | 53.0M | 52.5M | 44.8M | 21.3M |
| Effective Tax Rate % | 25.1% | 24.7% | 25.0% | 27.9% | 22.8% |
| Net Income | 181.6M | 161.4M | 157.1M | 115.7M | 72.1M |
| Net Margin % | 29.2% | 28.9% | 31.5% | 30.4% | 26.3% |
| Key Metrics | |||||
| EBITDA | 262.3M | 227.1M | 216.3M | 166.7M | 99.8M |
| EPS (Basic) | ₹15.13 | ₹13.45 | ₹13.09 | ₹9.64 | ₹8.16 |
| EPS (Diluted) | ₹15.13 | ₹13.45 | ₹13.09 | ₹9.64 | ₹8.16 |
| Basic Shares Outstanding | 12003000 | 12003000 | 12000000 | 12000000 | 8835000 |
| Diluted Shares Outstanding | 12003000 | 12003000 | 12000000 | 12000000 | 8835000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Prevest Denpro Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 609.0M | 486.1M | 390.0M | 423.2M | 164.2M |
| Short-term Investments | 47.0M | 16.6M | 11.9M | 7.3M | 4.4M |
| Accounts Receivable | 76.7M | 81.3M | 43.0M | 23.2M | 37.5M |
| Inventory | 80.4M | 62.4M | 47.9M | 32.6M | 12.7M |
| Other Current Assets | 3.0M | 1.9M | 744.0K | 593.0K | 593.0K |
| Total Current Assets | 857.2M | 680.7M | 543.2M | 527.0M | 236.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 14.0M | 13.6M | 3.2M | 4.8M | 4.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 268.1M | 267.5M | 74.1M | 114.4M | 70.7M |
| Total Assets | 1.1B | 948.2M | 617.2M | 641.4M | 306.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 16.2M | 11.9M | 14.0M | 16.4M | 39.1M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 9.2M | 11.9M | 2.4M | 4.1M | 3.7M |
| Total Current Liabilities | 59.6M | 55.1M | 54.4M | 54.0M | 65.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 0 | 0 | 0 | 13.7M | 13.9M |
| Deferred Tax Liabilities | 10.0M | 6.9M | 3.7M | 2.9M | 2.4M |
| Other Non-Current Liabilities | - | 1.0K | - | -25.0M | 1.0K |
| Total Non-Current Liabilities | 10.0M | 6.9M | 3.7M | 16.6M | 16.3M |
| Total Liabilities | 69.6M | 62.0M | 58.1M | 70.5M | 81.8M |
| Equity | |||||
| Common Stock | 120.0M | 120.0M | 120.0M | 120.0M | 2.8M |
| Retained Earnings | 733.6M | 564.1M | 405.9M | 248.8M | 217.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.1B | 886.2M | 728.0M | 570.9M | 225.0M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 0 | 13.7M | 13.9M |
| Working Capital | 797.5M | 625.6M | 488.8M | 473.0M | 170.6M |
Balance Sheet Composition
Prevest Denpro Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 242.5M | 214.3M | 209.6M | 160.5M | 93.4M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -20.3M | -37.6M | -40.9M | -11.8M | -16.8M |
| Operating Cash Flow | 185.4M | 151.8M | 152.6M | 135.7M | 73.3M |
| Investing Activities | |||||
| Capital Expenditures | -19.7M | -37.3M | -135.3M | -48.9M | -22.3M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -19.7M | -37.3M | -135.3M | -48.9M | -22.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -12.0M | -3.2M | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -12.0M | -3.2M | 0 | 266.1M | -1.3M |
| Free Cash Flow | 128.5M | 78.9M | -28.6M | 20.7M | 65.2M |
| Net Change in Cash | 153.7M | 111.3M | 17.3M | 352.9M | 49.6M |
Cash Flow Trend
Prevest Denpro Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.33
Price to Book
4.69
Price to Sales
7.59
PEG Ratio
6.44
Profitability Ratios
Profit Margin
27.78%
Operating Margin
28.67%
Return on Equity
17.20%
Return on Assets
16.13%
Financial Health
Current Ratio
15.06
Debt to Equity
0.00
Beta
0.56
Per Share Data
EPS (TTM)
₹16.51
Book Value per Share
₹96.29
Revenue per Share
₹59.43
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PREVEST | 5.4B | 27.33 | 4.69 | 17.20% | 27.78% | 0.00 |
| Poly Medicure | 151.0B | 43.53 | 5.17 | 12.24% | 19.51% | 8.17 |
| Dr Agarwal's Health | 138.9B | 109.80 | 7.17 | 4.33% | 6.38% | 48.68 |
| Tarsons Products | 11.0B | 55.45 | 1.81 | 4.72% | 4.91% | 63.18 |
| Laxmi Dental | 10.4B | 44.95 | 4.43 | 15.22% | 8.76% | 3.88 |
| Shree Pacetronix | 532.1M | 20.75 | 3.24 | 5.44% | 12.10% | 32.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.




